Commercial director, Rory O’Keeffe, Europlaz, examines the latest innovations that the team believes will be transformative to future clinical pathways.
Chris Whitehouse, political consultant and expert on medtech policy and regulation at Whitehouse Communications, advisor to medtech suppliers, chair of the Urology Trade Association, looks at the prognosis and treatment for the “broken” NHS.
Ahead of DxPx U.S., the industry + investor partnering conference dedicated to diagnostics, digital health, precision medicine, and life sciences tools, five key trends are emerging that are set to define the future of the industry.
Ashlee Gough at Sumitomo (SHI) Demag UK reviews the tipping point when injection moulding machinery loses its value, becomes financially unviable to maintain, and can hit you where it hurts most … on the bottom line.
After a historic general election in the UK, with the Conservatives ending up with the lowest number of seats in the party’s history, and Sir Keir Starmer becoming the nation’s Prime Minister, MTI reached out to contacts in the UK MedTech industry.
The 2024 Spring Budget announced a £4.2 billion boost for the healthcare sector. £3.4 billion of that is set aside for the NHS over three years to help the system work better, through increased investment in technology.
Dr Ameera Patel, CEO of TidalSense, an AI respiratory healthtech pioneer for COPD and asthma solutions, questions whether our healthcare systems have become too reliant on disposable medical devices.
Darryl Peterson, business development manager, Antares Vision Group, highlights the critical parameters to consider when installing an Automated Visual Inspection system per specific User Requirements Specifications (URS).
Joanne Belshaw, business development manager healthcare at ALBIS, explains how to maximise project team potential by leveraging plastic supplier’s support.
